NEO

Alicia C. Olivo

Known title: EVP, GC & Business DevelopmentCIK: 0001951869

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

NeoGenomics Shares Drop 12% on CEO Transition News. NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.

this person other insiders at NEO

Transaction History

NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▲ Buy$90K
NEO▼ Sell$251K
NEO▼ Sell$49K
NEO▼ Sell$0
NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▼ Sell$0
NEO▲ Buy$0
NEO▼ Sell$0
NEO▼ Sell$79K
NEO▼ Sell$0
NEO▼ Sell$17K
NEO▼ Sell$0
NEO▼ Sell$17K
NEO▲ Buy$0
NEO▼ Sell$24K
NEO▲ Buy$0
NEO▼ Sell$0
NEO▼ Sell$39K
NEO▼ Sell$49K
NEO▼ Sell$0
NEO▼ Sell$0
NEO▼ Sell$0
NEO▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.